Ibrahim Umar Garzali
Overview
Explore the profile of Ibrahim Umar Garzali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jalo R, Tsiga-Ahmed F, Kwaku A, Adamu A, Amole T, Garzali I, et al.
J Nephrol
. 2024 Dec;
PMID: 39724480
Background: Pregnancy-Related Acute Kidney Injury (PRAKI) is an important contributor to maternal-fetal morbidity and mortality. The burden of PRAKI in sub-Saharan Africa is not well documented. We conducted a systematic...
2.
Garzali I, ALoun A, Abuzeid E, Sheshe A
Hepatol Forum
. 2024 Oct;
5(4):211-216.
PMID: 39355837
The use of marginal grafts is very challenging and is associated with post-reperfusion syndrome and early allograft dysfunction. The outcomes of machine perfusion for the preservation of marginal grafts have...
3.
Usta S, Akbulut S, Sarici K, Garzali I, Ozdemir F, Gonultas F, et al.
J Clin Med
. 2024 May;
13(10).
PMID: 38792466
Treatment of established portal vein narrowing after living donor hepatectomy is challenging. We aimed to present a new approach termed the "elbow patch reconstruction technique" to correct the narrowed remnant...
4.
Garzali I, Carr B, Ince V, Isik B, Akatli A, Yilmaz S
Turk J Gastroenterol
. 2024 Mar;
35(2):143-149.
PMID: 38454246
Background/aims: Hepatocellular carcinoma is the main type of primary liver cancer. Macroscopic vascular invasion is usually identified during imaging, whereas microvascular invasion is usually determined by histopathological evaluation. We aim...
5.
Garzali I, Hargura A, Ince V, Varol F, Carr B, Yilmaz S
Turk J Gastroenterol
. 2023 Sep;
34(12):1235-1239.
PMID: 37681267
Background/aims: Liver transplantation is an acceptable treatment for some selected hepatocellular carcinoma. We report our experience of 6 patients with liver transplantation for hepatocellular carcinoma with background inherited metabolic disease....
6.
Garzali I, Akbulut S, ALoun A, Naffa M, Aksoy F
World J Gastrointest Surg
. 2023 Aug;
15(7):1522-1531.
PMID: 37555109
Background: The outcomes of liver transplantation (LT) from different grafts have been studied individually and in combination, but the reports were conflicting with some researchers finding no difference in both...
7.
Akbulut S, Yagin F, Sahin T, Garzali I, Tuncer A, Akyuz M, et al.
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445501
Background: In liver transplant (LT) recipients, immunosuppressive therapy may potentially increase the risk of severe COVID-19 and may increase the mortality in patients. However, studies have shown conflicting results, with...
8.
ALoun A, Abu-Zeid E, Garzali I
Hepatol Forum
. 2023 May;
4(2):82-88.
PMID: 37250931
Recurrence is still a problem after liver transplant for hepatocellular carcinoma (HCC). We performed an updated systematic review and meta-analysis of randomized controlled trials comparing tumor recurrence of mammalian target...
9.
Akbulut S, Bagci N, Akyuz M, Garzali I, Saritas H, Tamer M, et al.
Transplant Proc
. 2023 May;
55(5):1226-1230.
PMID: 37137762
Background And Aim: Many clinical studies have shown that the COVID-19 case fatality rate is higher in older patients, those with comorbidities, those with immunosuppressive conditions, and those who stay...
10.
Sarici K, Akbulut S, Uremis M, Garzali I, Kucukakcali Z, Koc C, et al.
Transplant Proc
. 2023 May;
55(5):1239-1244.
PMID: 37127514
Aim: This study aimed to evaluate the course of bone and mineral metabolism after liver transplantation (LT) in patients with chronic liver disease. Methods: One hundred four patients who had...